Growth Differentiation Factor 15 (GDF-15) Plasma Levels Increase during Bleomycin- and Cisplatin-Based Treatment of Testicular Cancer Patients and Relate to Endothelial Damage

Incremental Prognostic Power of Novel Biomarkers (Growth-Differentiation Factor-15, High-Sensitivity C-Reactive Protein, Galectin-3, and High-Sensitivity Troponin-T) in Patients With Advanced Chronic Heart Failure

(2013) Dirk J. Lok et al.   AMERICAN JOURNAL OF CARDIOLOGY

The multiple facets of the TGF-β family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1

(2013) Klaus Unsicker et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Anti-inflammatory cytokines and risk of type 2 diabetes

(2013) C. Herder et al.   DIABETES OBESITY & METABOLISM

Endothelial Damage in Long-Term Survivors of Childhood Cancer

(2013) Cornelia A.J. Brouwer et al.   JOURNAL OF CLINICAL ONCOLOGY

Growth-Differentiation Factor 15 Predicts Worsening of Albuminuria in Patients With Type 2 Diabetes

(2012) M. E. Hellemons et al.   DIABETES CARE

Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial

(2012) Tibor Kempf et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

The TGF-β superfamily cytokine, MIC-1/GDF15: A pleotrophic cytokine with roles in inflammation, cancer and metabolism

(2011) Samuel N. Breit et al.   GROWTH FACTORS

Impact of Long-Term Serum Platinum Concentrations on Neuro- and Ototoxicity in Cisplatin-Treated Survivors of Testicular Cancer

(2011) Mette Sprauten et al.   JOURNAL OF CLINICAL ONCOLOGY

GDF-15 promotes angiogenesis through modulating p53/HIF-1α signaling pathway in hypoxic human umbilical vein endothelial cells

(2011) Hejian Song et al.   MOLECULAR BIOLOGY REPORTS

Relations of growth-differentiation factor-15 to biomarkers reflecting vascular pathologies in a population-based sample of elderly subjects

(2011) Kai M. Eggers et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality

(2010) Fredrik E. Wiklund et al.   AGING CELL

Cardiovascular Risk Factors and Morbidity in Long-Term Survivors of Testicular Cancer: A 20-Year Follow-Up Study

(2010) Hege S. Haugnes et al.   JOURNAL OF CLINICAL ONCOLOGY

Cisplatin Reduces Endothelial Cell Migration Via Regulation of Type 2-Matrix Metalloproteinase Activity

(2009) Mercedes Montiel et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Acute hypoxia to endothelial cells induces activating transcription factor 3 (ATF3) expression that is mediated via nitric oxide

(2008) Shih-Chung Chen et al.   ATHEROSCLEROSIS

Cardiovascular risk in long-term survivors of testicular cancer

(2008) David J. Vaughn et al.   CANCER

Cisplatin up-regulates ICAM-1 expression in endothelial cell via a NF-κB dependent pathway

(2008) Minghua Yu et al.   CANCER SCIENCE

ATF3 and Fra1 have opposite functions in JNK- and ERK-dependent DNA damage responses

(2008) Mohamed Hamdi et al.   DNA REPAIR

Medical Treatment of Advanced Testicular Cancer

(2008) Darren R. Feldman   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION